D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 24,450 172 World Ranking 16092 National Ranking 8337

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Cancer

His main research concerns Internal medicine, Hepatitis C, Gastroenterology, Immunology and Cirrhosis. He studies Internal medicine, focusing on Hepatology in particular. His studies in Hepatitis C integrate themes in fields like Ribavirin, Hepatitis C virus, Regimen, Pharmacotherapy and Alpha interferon.

His Gastroenterology research is multidisciplinary, incorporating perspectives in Endocrinology, Liver transplantation and Liver biopsy. His Liver biopsy study which covers Fibrosis that intersects with Carcinoma. He interconnects Liver disease, Hepatocellular carcinoma, Surgery and Pathology in the investigation of issues within Cirrhosis.

His most cited work include:

  • Diagnosis, management, and treatment of hepatitis C: An update (2548 citations)
  • An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases (977 citations)
  • A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. (639 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Gastroenterology, Immunology, Hepatitis C and Cirrhosis are his primary areas of study. His work is connected to Liver disease, Hepatocellular carcinoma, Hepatology, Liver biopsy and Hepatitis B, as a part of Internal medicine. His studies deal with areas such as Fibrosis, Biopsy and Cohort as well as Gastroenterology.

His work in Immunology addresses issues such as Virology, which are connected to fields such as Antigen. His Hepatitis C research includes elements of Pegylated interferon, Ribavirin, Hepatitis C virus, Pathology and Pharmacotherapy. His Cirrhosis study integrates concerns from other disciplines, such as Decompensation, Prospective cohort study, Surgery and Liver transplantation.

He most often published in these fields:

  • Internal medicine (56.93%)
  • Gastroenterology (40.59%)
  • Immunology (39.11%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (56.93%)
  • Hepatitis B (19.31%)
  • Gastroenterology (40.59%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Hepatitis B, Gastroenterology, Hepatitis B virus and Cirrhosis. His Internal medicine research incorporates themes from Coinfection and HBsAg, HBeAg. His research on Hepatitis B also deals with topics like

  • Chronic hepatitis together with Viremia,
  • Virus and related Immune system, Inflammation, Clinical trial, Hepatitis C and Disease.

His biological study spans a wide range of topics, including Fibrosis and Biopsy, Liver biopsy. His research integrates issues of Clinical significance, Interquartile range, Hepatology and Hepatitis in his study of Hepatitis B virus. While the research belongs to areas of Cirrhosis, he spends his time largely on the problem of Hepatocellular carcinoma, intersecting his research to questions surrounding Hepatitis C virus, Interferon and Immunology.

Between 2018 and 2021, his most popular works were:

  • Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection (115 citations)
  • Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡ (44 citations)
  • Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease (21 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Diagnosis, management, and treatment of hepatitis C: An update

Marc G. Ghany;Doris B. Strader;David L. Thomas;Leonard B. Seeff.
Hepatology (2009)

4168 Citations

An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

Marc G. Ghany;David R. Nelson;Doris B. Strader;David L. Thomas.
Hepatology (2011)

1486 Citations

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.

Kittichai Promrat;Glen Lutchman;Gabriel I. Uwaifo;Renee J. Freedman.
Hepatology (2004)

948 Citations

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie.
Gastroenterology (2009)

706 Citations

Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
Hepatology (2007)

669 Citations

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima.
Gastroenterology (2004)

649 Citations

Outcome of sustained virological responders with histologically advanced chronic hepatitis C

Timothy R. Morgan;Timothy R. Morgan;Marc G. Ghany;Hae Young Kim;Kristin K. Snow.
Hepatology (2010)

575 Citations

Current and future therapies for hepatitis C virus infection.

T. Jake Liang;Marc G. Ghany.
The New England Journal of Medicine (2013)

546 Citations

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

Adrian M. Di Bisceglie;Mitchell L. Shiffman;Gregory T. Everson;Karen L. Lindsay.
The New England Journal of Medicine (2008)

537 Citations

Long‐term therapy of chronic hepatitis B with lamivudine

Daryl T.‐Y. Lau;M. Farooq Khokhar;Edward Doo;Marc G. Ghany.
Hepatology (2000)

524 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Marc G. Ghany

Stefan Zeuzem

Stefan Zeuzem

Goethe University Frankfurt

Publications: 113

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 88

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 85

Kazuaki Chayama

Kazuaki Chayama

Hiroshima University

Publications: 84

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 84

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 82

Mitchell L. Shiffman

Mitchell L. Shiffman

Bon Secours Health System

Publications: 77

Jean-Michel Pawlotsky

Jean-Michel Pawlotsky

Université Paris Cité

Publications: 77

Ira M. Jacobson

Ira M. Jacobson

New York University

Publications: 75

Mark S. Sulkowski

Mark S. Sulkowski

Johns Hopkins University School of Medicine

Publications: 71

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 69

Norah A. Terrault

Norah A. Terrault

University of Southern California

Publications: 64

Raymond T. Chung

Raymond T. Chung

Harvard University

Publications: 61

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 59

Harry L.A. Janssen

Harry L.A. Janssen

University Health Network

Publications: 59

Nezam H. Afdhal

Nezam H. Afdhal

Beth Israel Deaconess Medical Center

Publications: 59

Trending Scientists

Patric H. Hendershott

Patric H. Hendershott

University of Aberdeen

Hermann Kopetz

Hermann Kopetz

TU Wien

Hongjun Lu

Hongjun Lu

Hong Kong University of Science and Technology

Qianqian Li

Qianqian Li

Wuhan University

Olaf S. Andersen

Olaf S. Andersen

Cornell University

Louis Fieser

Louis Fieser

Harvard University

Ralph E. J. Boerner

Ralph E. J. Boerner

The Ohio State University

Kiwamu Minamisawa

Kiwamu Minamisawa

Tohoku University

N. H. Ravindranath

N. H. Ravindranath

Indian Institute of Science

Daphne R. Goring

Daphne R. Goring

University of Toronto

Axel Janke

Axel Janke

Goethe University Frankfurt

David R. S. Lean

David R. S. Lean

University of Ottawa

John H. Riskind

John H. Riskind

George Mason University

Andrea Fagiolini

Andrea Fagiolini

University of Siena

Patrick J. Bayer

Patrick J. Bayer

Duke University

Valentina D'Orazi

Valentina D'Orazi

National Institute for Astrophysics

Something went wrong. Please try again later.